HOME    NEWSLETTER ARCHIVE    CME/CNE/CPE INFORMATION    PROGRAM DIRECTORS    EDIT PROFILE    RECOMMEND TO A COLLEAGUE


Accreditation Statements

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of The Johns Hopkins University School of Medicine, The Institute for Johns Hopkins Nursing and Tufts University School of Medicine.

The Johns Hopkins University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Nurses
The Institute for Johns Hopkins Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Pharmacists
Tufts University School of Medicine, Office of Continuing Education is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.



Credit Designations

Physicians
eNewsletter: The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 1.0 AMA PRA Category1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Podcast: The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Nurses
eNewsletter: This 1 contact hour Educational Activity is provided by The Institute for Johns Hopkins Nursing. Each newsletter carries a maximum of 1 contact hour or a total of 12 contact hours for the twelve newsletters in this program.

Podcast: This 0.5 contact hour Educational Activity is provided by The Institute for Johns Hopkins Nursing. Each podcast carries a maximum of 0.5 contact hours or a total of 3.0 contact hours for the six podcasts in this program.

Pharmacists
This program is available for 1 contact hour per newsletter and .5 contact hours per podcast. Universal Program Number: 054-999-08-002-H01-P through 054-999-08-019-H01-P.

Type of continuing pharmacy education activity: Knowledge-based

Successful Completion

To successfully complete this activity, participants must read the content, complete the post-test with a passing grade of 70%, and complete the evaluation. Participants can access and print statements of credit after successful completion of this activity.

General CPE Information

For questions regarding continuing pharmacy education, contact Tufts University School of Medicine (TUSM), Office of Continuing Education (OCE) at med-oce@tufts.edu.

TUSM Privacy and Confidentiality statement can be found at: http://www.tufts.edu/med/about/offices/oce/privacy.html

There are no fees associated with this activity.

This activity is supported by an educational grant from ViroPharma, Inc.

Post-Test

To take the post-test for eTransplantID Review you will need to access The Johns Hopkins University School of Medicine, The Institute for Johns Hopkins Nursing or the Tufts University School of Medicine, Office of Continuing Education (for ACPE credit) websites; links are provided throughout the website and newsletters. If you have already registered for other Hopkins CE programs at these sites, simply enter the requested information when prompted. Otherwise, complete the registration form to begin the testing process. A passing grade of 70% or higher on the post-test/evaluation is required to receive CE credit.

Statement of Responsibility

The Johns Hopkins University School of Medicine, The Institute for Johns Hopkins Nursing and the Tufts University School of Medicine take responsibility for the content, quality and scientific integrity of this CME/CNE/CPE activity.

Intended Audience

The primary target audiences for this program are solid organ and bone marrow/stem cell transplant specialists, including: infectious disease specialists, hematologists, cardiologists, hepatologists, nephrologists, oncologists, transplant surgeons, abdominal surgeons, nurse practitioners, nurse coordinators, nurses, and pharmacists.

Learning Objectives

At the conclusion of this activity, participants should be able to:
  • Discuss with colleagues how recently published clinical trial data can be applied to diagnosing infectious diseases presenting in their transplant recipient patients
  • Describe to colleagues the most effective evidence-based treatments for managing infectious diseases in transplant recipients
  • Integrate these new data into current ID practice paradigms to improve patient outcomes
Launch Date

March 2009; activities expire 2 years from the date of publication ending in February, 2011.

Internet CME/CPE Policy

The Office of Continuing Medical Education (CME) at The Johns Hopkins University School of Medicine, The Institute for Johns Hopkins Nursing and the Tufts University School of Medicine, Office of Continuing Education are committed to protecting the privacy of its members and customers. The Johns Hopkins University maintains its Internet site as an information resource and service for physicians, other health professionals and the public.

Continuing Medical Education at The Johns Hopkins University School of Medicine, The Institute for Johns Hopkins Nursing and the Tufts University School of Medicine Office of Continuing Education will keep your personal and credit information confidential when you participate in a CE Internet-based program. Your information will never be given to anyone outside these institutions. CE collects only the information necessary to provide you with the service you request.

Faculty Disclosure

As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of Johns Hopkins University School of Medicine to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a provider has with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. The presenting faculty reported the following:

Kieren A. Marr, MD - Dr. Marr discloses that she received grant/research support from Enzon and Merck & Co., Inc. and has served as a consultant to Astellas, Basilea, Merck & Co., Pfizer Inc, and Schering-Plough.

Aruna K. Subramanian, MD - Dr. Subramanian discloses that for serving as a Principal Investigator for Chimerix, she has received grant/research support. She has also served as a consultant to ViroPharma, Inc.

Michael G. Ison, MD, MS - Dr. Ison discloses that he has received grant/research support for serving as a Principal Investigator for ADMA, BioCryst, Pfizer Inc, Roche, ViraCor, and ViroPharma, Inc. He has received honoraria from Abbott Molecular and ViraCor as well as other financial or material support from Chimerix.

Kenneth R. Lawrence, BS, PharmD - Dr. Lawrence discloses that he has received grant/research support for his role as a Principal Investigator for Merck & Co., and AstraZeneca. Additionally, he has served as a consultant for Johnson & Johnson and is on the Speakers’ Bureaus of Astellas, Merck & Co., Pfizer Inc, and Wyeth.

Michelle Felix, RN, MSN, CPNP - Ms. Felix does not have any financial relationships to disclose.

Disclaimer Statement

The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of The Johns Hopkins University School of Medicine, The Institute for Johns Hopkins Nursing and The Tufts University School of Medicine, Office of Continuing Education name(s) implies review of educational format design and approach. Please review the complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.

Hardware & Software Requirements

Pentium 800 processor or greater, Windows 98/NT/2000/XP or Mac OS 9/X, Microsoft Internet Explorer 5.5 or later, 56K Modem or better,Windows Media Player 9.0 or later, 128 MB of RAM Monitor settings: High color at 800 x 600 pixels, Sound card and speakers, Adobe Acrobat Reader.


Copyright © JHUSOM, IJHN, TUSM-OCME and eTransplantID Review   •   Created by DKBmed.












 

PRIVACYLEGAL DISCLAIMERCONTACT US